Marking the occasion with a ceremony, Genentech, a member of the Roche Group, has announced the construction of a new biologics manufacturing facility at its Oceanside, CA campus.
The new facility will harness transformational digital technologies to move medicines from production to patients faster and more sustainably, making it one of the most modern commercial-scale biotech manufacturing facilities in the world. Sustainable design has been integrated into the facility from construction to production, making it more environmentally friendly than traditional manufacturing facilities, and…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
